A carregar...
Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
There is increasing interest in rituximab (RTX) as an alternative to cyclophosphamide for the treatment of interstitial lung diseases (ILDs) associated with systemic sclerosis (SSc). However, no report has addressed its efficacy in Saudi patients with SSc-ILD. To assess the efficacy of RTX treatment...
Na minha lista:
| Publicado no: | Ann Thorac Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5656950/ https://ncbi.nlm.nih.gov/pubmed/29118864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/atm.ATM_30_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|